In addition to the presence of appropriate clinical features, the diagnosis of the
antiphospholipid antibody syndrome (APS) fundamentally requires the finding of positive …

The presence of antiphospholipid antibodies (aPL) is essential to diagnose the
antiphospholipid syndrome (APS). Three assays are available to detect the presence of …

The 2023 ACR/EULAR antiphospholipid syndrome (APS) classification criteria have recently
been published [1], replacing the prior criteria established in 2006 [2]. Designed primarily for …

The laboratory diagnosis of the antiphospholipid syndrome (APS) via antiphospholipid
antibody (aPL) tests, including lupus anticoagulant (LAC), anti-cardiolipin (aCL), or anti …

Anticardiolipin (aCL) and anti-β2 glycoprotein I (anti-β2GPI) assays are widely performed
because they are part of the laboratory criteria for the antiphospholipid syndrome (APS) …

Current classification criteria for definite Antiphospholipid Syndrome (APS) require the use
of three laboratory assays to detect antiphospholipid antibodies (aCL, anti-β2GPI and LA) in …

The updated international consensus criteria for definite antiphospholipid syndrome (APS)
are useful for scientific clinical studies. However, there remains a need for diagnostic criteria …

Antiphospholipid syndrome (APS) is a hypercoagulation condition associated with the
incidence of heterogenic antiphospholipid antibodies (aPLs), which non-specifically affect …

Anticardiolipin antibodies (aCL), anti-β2-glycoprotein I (β2GPI) antibodies and lupus
anticoagulant (LA) are the only laboratory tests considered within the revised criteria for the …

Background Improving harmonization of the clinical interpretation of anticardiolipin (aCL)
and anti-β2-glycoprotein I antibodies (aβ2GPI) IgG/IgM in the diagnosis of antiphospholipid …